Atlas Trials

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

Clinical trial NCT02316847 · TERMINATED

Trial details

NCT number
NCT02316847
Sponsor
Acorda Therapeutics
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Epilepsy
Start date
2014-12-01
Primary completion
2016-07-01
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.